Prof. Yumei Li | Cancer Biology | Young Scientist Award

Gannan Medical University, China

Prof. Yumei Li focuses on uncovering the molecular mechanisms by which ribosome biogenesis regulates tumorigenesis and metastasis, with the goal of identifying biomarkers, therapeutic targets, and developing precise targeted cancer therapies. Her research has demonstrated the oncogenic roles of WDR74 and NOL7 and highlighted the therapeutic potential of targeting ribosome biogenesis. She has published over 20 high-quality SCI-indexed papers in leading journals, contributing significantly to cancer biology and translational medicine. As a principal investigator, she leads multiple national and provincial research projects. Her work is supported by granted patents, including innovations in diagnostic kits and anti-tumor drug development. She actively contributes to academia as a youth editorial board member and maintains international research collaborations. Her studies provide critical insights into tumor progression mechanisms. She has established a strong theoretical and technical foundation for future innovations. Her research advances precision oncology strategies. Overall, her contributions significantly impact tumor pathogenesis research and targeted cancer therapy development.